A phase II study of irinotecan, 5-fluorouracil and leucovorin for treatment in patients with previously untreated advanced colorectal cancer. - Wikidata - awgldk - TriplyDB

A phase II study of irinotecan, 5-fluorouracil and leucovorin for treatment in patients with previously untreated advanced colorectal cancer.

A phase II study of irinotecan, 5-fluorouracil and leucovorin for treatment in patients with previously untreated advanced colorectal cancer.

http://www.wikidata.org/entity/Q37341713

about

Successful treatment of small-cell lung cancer with irinotecan in a hemodialysis patient with end-stage renal disease.

P2860

Q41778610-8D0B6DB4-6A90-4838-8A04-480CB706F28D

P2860

A phase II study of irinotecan, 5-fluorouracil and leucovorin for treatment in patients with previously untreated advanced colorectal cancer.

http://www.wikidata.org/entity/Q37341713

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 30 April 2006

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A phase II study of irinotecan ...... ed advanced colorectal cancer.

@en

A phase II study of irinotecan ...... ed advanced colorectal cancer.

@nl

type

label

A phase II study of irinotecan ...... ed advanced colorectal cancer.

@en

A phase II study of irinotecan ...... ed advanced colorectal cancer.

@nl

prefLabel

A phase II study of irinotecan ...... ed advanced colorectal cancer.

@en

A phase II study of irinotecan ...... ed advanced colorectal cancer.

@nl

P1433

Q37341713-AC86870E-7440-4D75-9697-7B90DC625126

P1476

Q37341713-2CC7D854-DF00-4B16-8A2D-2F72178AE620

P2093

Q37341713-349635FF-B642-486E-8911-5B47C3DC4BD8

Q37341713-397A068D-D4FA-45DD-8C8F-E186361B174F

Q37341713-53A0F758-48B8-4111-A4ED-4D7760D68A4C

Q37341713-6F2A7C4A-B2BC-4516-9D88-F3AC7170B933

Q37341713-8DC20126-C0E1-4B13-97DD-8DD4AACDDA69

Q37341713-A86C5925-81F7-47F4-B407-AF366E3ADD90

Q37341713-ADA368CD-C228-4776-B11E-5CF8211B6B25

Q37341713-B13934A4-D98C-43CC-98EA-1CAC776F0641

Q37341713-C1F313DB-230F-4788-877D-6C69D8966024

Q37341713-CEB2A5E3-2558-4AEF-9272-DA000B6FC3E3

P2860

Q37341713-0E0AE049-EE47-4C6F-AA4E-2329CDFB67A8

Q37341713-25895897-5E2C-4962-9445-88FDA12491E4

Q37341713-296AE8D4-4159-4352-8D5C-FBBD9157319D

Q37341713-65CECE21-FF42-45A5-8973-90FE08BFF5EB

Q37341713-6EEA8789-7669-4E37-AC4C-B09EDFF1CE33

Q37341713-C14530EB-BD77-4B08-BF6D-0F66929CB243

Q37341713-C986F575-8817-4E9D-B7CA-1207E3B1AD8F

Q37341713-D0733C09-0C64-48CF-897D-BA74B184EF2B

P304

Q37341713-6A30949A-2EEE-42ED-9A89-2BF0B732250C

P31

Q37341713-D8AF0BF0-C8B5-4A87-BC65-C7374BEB897C

P356

Q37341713-777DF5B3-EF20-4B24-B983-816D167F420A

P433

Q37341713-7594DCBE-7EB7-41C6-A61B-09C461C89C6B

P478

Q37341713-57B4AD6A-A17C-4A1C-9345-8F0503ED5A10

P577

Q37341713-D004A18C-A7A8-4619-9654-8C15395430AE

P5875

Q37341713-0ABD5A66-4339-4887-9465-FA9BDA5C32E5

P698

Q37341713-0809A9A6-5B67-4A18-8CBB-F688D945E7B6

P921

Q37341713-3D74A9C9-E293-4321-91A8-EE60CF895398

P932

Q37341713-C9F4565E-583F-47B9-82D3-0778395C7875

P356

CRT.2006.38.2.72

P1433

Cancer Research and Treatment

P1476

A phase II study of irinotecan ...... ed advanced colorectal cancer.

@en

P2093

Chan-Kyu Kim

http://www.w3.org/2001/XMLSchema#string

Dae-Sik Hong

http://www.w3.org/2001/XMLSchema#string

Han-Jo Kim

http://www.w3.org/2001/XMLSchema#string

Hee-Sook Park

http://www.w3.org/2001/XMLSchema#string

Hyun-Jung Kim

http://www.w3.org/2001/XMLSchema#string

Jong-Ho Won

http://www.w3.org/2001/XMLSchema#string

Kyoung-Ha Kim

http://www.w3.org/2001/XMLSchema#string

Kyu-Taeg Lee

http://www.w3.org/2001/XMLSchema#string

Nam-Su Lee

http://www.w3.org/2001/XMLSchema#string

Sang-Byung Bae

http://www.w3.org/2001/XMLSchema#string

P2860

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial

FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study

Phase II study of irinotecan, 5-fluorouracil, and leucovorin in relapsed or metastatic colorectal cancer as first-line therapy

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.

A systematic overview of chemotherapy effects in colorectal cancer.

Fluorouracil in colorectal cancer--a tale of two drugs: implications for biochemical modulation.

P304

72-77

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4143/CRT.2006.38.2.72

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

38

http://www.w3.org/2001/XMLSchema#string

P577

2006-04-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26828627

http://www.w3.org/2001/XMLSchema#string

P698

19771263

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer

P932

2741663

http://www.w3.org/2001/XMLSchema#string